NZ516564A - Cancer therapy - Google Patents

Cancer therapy

Info

Publication number
NZ516564A
NZ516564A NZ516564A NZ51656400A NZ516564A NZ 516564 A NZ516564 A NZ 516564A NZ 516564 A NZ516564 A NZ 516564A NZ 51656400 A NZ51656400 A NZ 51656400A NZ 516564 A NZ516564 A NZ 516564A
Authority
NZ
New Zealand
Prior art keywords
cancer therapy
medicament
agent
eradicating
retarding
Prior art date
Application number
NZ516564A
Inventor
Geoffrey Wayne Krissansen
Jagat Rakesh Kanwar
Lai-Ming Hing
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Priority to NZ516564A priority Critical patent/NZ516564A/en
Priority claimed from PCT/NZ2000/000098 external-priority patent/WO2000076497A1/en
Publication of NZ516564A publication Critical patent/NZ516564A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A use of a immunotherapeutic agent and a tumour growth- restricting agent in the preparation of a medicament for retarding or eradicating an advanced or large tumour burden wherein said medicament is formulated for simultaneous, separate or sequential administration of the agents.
NZ516564A 1999-06-14 2000-06-14 Cancer therapy NZ516564A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ516564A NZ516564A (en) 1999-06-14 2000-06-14 Cancer therapy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ33625999 1999-06-14
NZ516564A NZ516564A (en) 1999-06-14 2000-06-14 Cancer therapy
PCT/NZ2000/000098 WO2000076497A1 (en) 1999-06-14 2000-06-14 Cancer therapy

Publications (1)

Publication Number Publication Date
NZ516564A true NZ516564A (en) 2003-10-31

Family

ID=29253761

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ516564A NZ516564A (en) 1999-06-14 2000-06-14 Cancer therapy

Country Status (1)

Country Link
NZ (1) NZ516564A (en)

Similar Documents

Publication Publication Date Title
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
MXPA03010121A (en) Combination therapy using anti-egfr antibodies and anti-hormonal agents.
HK1046093A1 (en) Docetaxel in combination with rhumab her2 for the treatment of cancers.
IL155781A0 (en) Effective antitumor treatments
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
MY164077A (en) Compositions and uses of et743 for treating cancer
IL182352A0 (en) The use of et-743 in the preparation of a medicament for treating cancer and medical kits containing et-743
HK1068606A1 (en) Novel aminobenzoephenones
NZ504938A (en) Tumor antigen peptide derivatives capable of binding to HLA-A24 antigen
EP0663835A1 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
NZ504928A (en) Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
WO2000040229A3 (en) Synergistic tumorcidal response induced by histamine
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
NO943288L (en) Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease
NZ511150A (en) Non-fermented osmotic laxative for treating and preventing colorectal cancers
HK1053424A1 (en) The use of exemestane for the preparation of a medicament for the first-line treatment of breast cancer
ZA877901B (en) Active compounds for use in the treatment of tumors
AU2001236529A1 (en) Combination therapy for cancer
NZ516564A (en) Cancer therapy
MXPA05009849A (en) Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor.
YU29803A (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
AR109456A2 (en) USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY
WO2000037065A3 (en) Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
NZ501641A (en) Ganglioside immunostimulating complexes and their use in treating cancer

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: CANCER RESEARCH TECHNOLOGY LIMITED, GB

Free format text: OLD OWNER(S): CANCER RESEARCH VENTURES LIMITED

PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed